EE rats treated with anti-IL-17A antibodies exhibited significantly reduced protein expression of CD34 in penumbra at 21 days after stroke compared with those in the EE and EE + isotype groups (P < 0.01, Figures 3C, D). The gene discussed is CD34; the disease is stroke disorder.